
CVS Health Corporation (CVS)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
83.29 - Open
83.45 - Bid --
- Ask --
- Day's Range
82.07 - 83.74 - 52 Week Range
58.35 - 85.15 - Volume
3,823,701 - Avg. Volume
7,868,132 - Market Cap (intraday)
105.207B - Beta (5Y Monthly) 0.50
- PE Ratio (TTM)
59.06 - EPS (TTM)
1.39 - Earnings Date May 6, 2026
- Forward Dividend & Yield 2.66 (3.24%)
- Ex-Dividend Date Apr 23, 2026
- 1y Target Est
96.58
Recent News: CVS
View MorePerformance Overview: CVS
Trailing total returns as of 5/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends: CVS
View MoreAnalyst Insights: CVS
View MoreStatistics: CVS
View MoreValuation Measures
-
Market Cap
105.21B
-
Enterprise Value
174.56B
-
Trailing P/E
59.06
-
Forward P/E
11.47
-
PEG Ratio (5yr expected)
0.24
-
Price/Sales (ttm)
0.26
-
Price/Book (mrq)
1.40
-
Enterprise Value/Revenue
0.43
-
Enterprise Value/EBITDA
17.70
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.44%
-
Return on Assets (ttm)
2.47%
-
Return on Equity (ttm)
2.29%
-
Revenue (ttm)
399.83B
-
Net Income Avi to Common (ttm)
1.77B
-
Diluted EPS (ttm)
1.39
Balance Sheet and Cash Flow
-
Total Cash (mrq)
10.6B
-
Total Debt/Equity (mrq)
106.06%
-
Levered Free Cash Flow (ttm)
5.93B
Compare To: CVS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights: CVS
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: CVS
View More-
US Large Cap Pick List - April 2026
This pick list highlights constituents of the Morningstar US Large Cap Index that we believe offer investors the best risk-adjusted return prospects. Stocks of large-cap companies where neither growth nor value characteristics predominate. Stocks in the top 70% of the capitalization of the U.S. equity market are defined as large cap.
-
Managed-Care Shares Rise on Improvement in Final Medicare Advantage Rate Notice
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
RatingPrice Target -
CVS Remains in Turnaround Mode, Shooting for Ambitious Targets Through 2028
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
RatingPrice Target -
The Argus High-Yield Model Portfolio
Value stocks -- a market segment that includes high-yield stocks -- outperformed growth stocks in 2022. In 2025, value stocks and growth stocks had similar returns, with growth advancing 13.8% and value returning 13.6%. That's a recent rarity, as for the past decade-plus, the performance record has favored growth. But in 2022, the rollout of COVID-19 vaccines gave a lift to some of the cyclical companies (energy and regional banks), and value stocks outpaced growth stocks that year. While growth stocks led for a few years after that, value stocks are back in the picture as investors rotate out of higher-priced AI growth stocks in search of more reasonable valuations. Value stocks tend to be more resilient in times of market uncertainty and higher volatility as they are less likely to overreact to economic news. In any event, the value sector is the place to achieve income.







